Sergei Atamas,
M.D., Ph.D.  410-605-7000 x6468 or 410-706-6474
Department of Microbiology and Immunology Department of Medicine
Research: Immune and inflammatory mechanisms of tissue fibrosis
|
Laure Aurelian,
Ph.D. 410-706-3895
Department of Pharmacology and Experimental Therapeutics
Research: Ongoing studies are focused on understanding the molecular mechanism of H11 induced apoptosis, its regulation and its role in melanoma development.
|
Abdu Azad,
Ph.D. 410-706-3335
Department of Microbiology and Immunology
Research: Our long-term goal is to assess the importance of rickettsial genes encoding virulence-associated proteins and their use in immunoprotection against pathogenic rickettsiae.
|
Eileen Barry,
Ph.D. 410-706-3702
Department of Medicine/Center for Vaccine Development
Research: The research in my laboratory is focused on the development of live, attenuated bacterial strains which can be used as vaccines delivered by the oral route.
|
Patrik Bavoil,
Ph.D. 410-706-6789
Department of Microbial Pathogenesis
Research: Chlamydia genomics; Molecular pathogenesis of Chlamydia species and chlamydiaphages
|
Tom Blanchard,
Ph.D. 410-706-1772
Department of Pediatrics
Research: My primary interests involve immune regulation and response in the gastrointestinal tract where the body is in continuous contact with commensal and pathogenic bacteria.
|
Nicholas Carbonetti,
Ph.D. 410-706-7677
Department of Microbiology and Immunology
Research: Bordetella pertussis infection of the respiratory tract and the role of pertussis toxin in immunosuppression and virulence
|
Gregory Carey,
Ph.D. 410-706-8191
Department of Microbiology and Immunology
Research: We are investigating protein kinases in the PI3K/Akt and Ras signaling pathways and exploring ways to specifically activate protein phosphatases for tumor cell eradication and to better understand better immune function. Our research combines biological, biochemical, molecular and proteomics approaches.
|
Jan Cerny,
M.D., Ph.D. 410-706-7114
Department of Microbiology and Immunology
Research:
|
Alan Cross,
M.D. (410) 328-2565
Department of Medicine
Research: Development of bacterial vaccines; role of Gram-negative bacterial lipopolysaccharide (LPS) in innate immunity; host defense mechanisms against bacterial infections; role of sialidase (neuraminidase) in the inflammatory process; clinical trials in immunocompromised hosts.
|
Shiladitya DasSarma,
410-234-8847
University of Maryland Biotechnology Institute
Research: Archaeal genomics, post-genomics and biotechnology
|
Anthony DeVico,
Ph.D. 410-706-4680
Institute of Human Virology
Research: neutralizing immune response against the co-receptor binding domain of HIV-1 gp120
|
Michael Donnenberg,
M.D. 410-706-7562
Department of Medicine
Research: Molecular Pathogenesis of E. coli Infections
|
Robert (Bob) Ernst,
PhD 410-706-3622
Microbial Pathogenesis
Research: The major focus of my lab is to investigate the mechanisms by which gram-negative bacteria modify the lipid A component of lipopolysaccharide and how these alterations affect the host innate immune system.
|
Donna Farber,
Ph.D. 410-706-7458
Department of Surgery
Research: The focus of my research is on CD4 T cell memory and peripheral T cell differentiation.
|
Ricardo Feldman,
Ph.D. 410-706-4197
Department of Microbiology and Immunology
Research: Molecular mechanisms regulating the self-renewal, mobilization and tissue regeneration properties of adult and embryonic stem cells
|
Martin Flajnik,
Ph.D. 410-706-5161
Department of Microbiology and Immunology
Research: My work is centered on the evolution of the immune system, with the major goal being to understand the origins of adaptive immunity.
|
Ashraf Fouad,
D.D.S. 410-706-7047
Department of Endodontics, Prothodontics & Operative Dentistry
Research: Microbial analysis of endodontic infections; Endodontic treatment outcomes; Determination of effective endodontic antimicrobial agents
|
Claire Fraser-Liggett,
Ph.D. 410-706-3879
Institute for Genome Sciences
Research: Metagenomics of human intestinal and oral microbiomes in health and disease
|
Mathew B. Frieman,
PhD (410) 706-2539
Microbiology & Immunology
Research: The interaction between the SARS-CoV and the host during infection
|
Robert Gallo,
M.D. 410-706-8614
Institute of Human Virology
Research: the development of an effective HIV preventive vaccine and the development of innovative HIV therapies
|
Ronald Gartenhaus,
M.D. 410-328-3691
Department of Medicine
Research: Lymphomagenesis; Molecular Genetics; Translational regulation
|
Alfredo Garzino-Demo,
Ph.D. 410-706-4689
Institute of Human Virology
Research: role of chemokines that bind to CCR5 in protection from infection and disease progression
|
Anthony Gaspari,
M.D. 410-328-5766
Department of Dermatology
Research: T-lymphocyte mediated allergic skin diseases, antigen presentation by resident epidermal cells such as Langerhans cells and keratinocytes to skin homing lymphocytes, and immunopharmacology
|
Patricia Gearhart,
Ph.D. 410-558-8561
National Institute of Aging
Research: Biochemical and functional interactions of proteins that have been implicated in the error-prone repair pathway mediating somatic hypermutation of immunoglobulin genes
|
Bret Hassel,
Ph.D. 410-328-2344
Department of Microbiology and Immunology
Research: My laboratory studies two pathways of interferon action that are involved in the antiviral and tumor suppressive activities of interferon.
|
Dhan Kalvakolanu,
M.S. 410-328-1396
Department of Microbiology and Immunology
Research: The major research interests of Dr. Kalvakolanu's lab are regulation of gene transcription and signal transduction by cytokines; Tumor cell growth control; and Regulation of novel Cell death-activating genes.
|
Roberta Kamin-Lewis,
Ph.D. 410-706-4886
Deparrment of Microbiology and Immunology
Research: human host defense mechanisms with emphasis on mucosal immunity (immunity in the major tracts-GI, genital-urinary, oral cavity, etc) and HIV-1 vaccine development.
|
James Kaper,
Ph.D. 410-706-2344
Department of Microbiology and Immunology
Research: Research in my laboratory focuses on the molecular pathogenesis of enteric bacterial pathogens.
|
Achsah Keegan,
Ph.D. 410-706-8174
Department of Microbiology and Immunology
Research: The major goal of our lab is to gain an understanding of the molecular mechanism by which IL-4 mediates its diverse array of biological effects with the future goal of developing rational strategies for manipulating immune responses.
|
Myron M. Levine,
M.D., D.T.P.H. 410-706-7588
Department of Medicine
Research: Overview Pathogenesis of bacterial diarrheas; enteric vaccine development; field epidemiologic studies of bacterial enteric infections. Research Interests Development of vaccines against enteric infections.
|
George Lewis,
Ph.D. 410-706-4688
Institute of Human Virology
Research: Development of Mucosal Vaccines Against HIV-1; The Role of Glycosaminoglycan Binding in the Biological Activities of b-chemokines
|
Ferenc Livak,
M.D. (410) 706-0747
Department of Microbiology and Immunology
Research: Our ultimate goal is to integrate the function of the lymphoid specific and ubiquitous external signals as well as the cell-autonomous transcriptional program into a coherent framework of lymphocyte differentiation.
|
Wuyuan Lu,
Ph.D. 410-706-4890
UMBI and Department of Chemistry and Biochemistry, UMBC
Research: Chemical Protein Engineering via Native Chemical Ligation;
Viral Proteins in HIV-1 Assembly and Maturation;
Targeting Tumorigenic Proteins for Cancer Therapy;
Structure and Function Relationships for Proteins in Innate Host Defense
|
Igor Lukashevich,
M.D., Ph.D. 410-706-1366
Department of Medicine
Research: Lassa Hemorrhagic Fever (LHF) virus pathogenesis and vaccine development
|
Dean Mann,
M.D. 410-328-5512
Department of Pathology
Research: Human Immunology, with an emphasis on the genetic control of the immune response as related to disease pathogenesis and treatment
|
Andrei Medvedev,
Ph.D. 410-706-5854
Department of Microbiology and Immunology
Research: My research focuses on mechanisms of signal transduction by innate sensors of microbial pathogens, Toll-like receptors, and their dysregulation in endotoxin tolerance and tolerance-like states.
|
Gregory Melikian,
Ph.D. 410-706-4781
Institute of Human Virology
Research: The main focus of our group is the molecular mechanism by which human immunodeficiency virus (HIV) and Rous sarcoma virus induce membrane fusion that leads to virus entry.
|
Kamal Moudgil,
M.D., Ph.D. 410-706-7804
Department of Microbiology and Immunology
Research: antigen processing and presentation; induction and regulation of autoimmune arthritis
|
Garry Myers,
Ph.D. 410-706-5678
Institute for Genomic Sciences
Research: Comparative and Functional Genomics of the Chlamydiales and Coxiella burnetii, and metagenomics of the normal human vaginal microbiome
|
James Nataro,
M.D., Ph.D. 410-706-8442
Department of Pediatrics
Research: My laboratory studies the molecular pathogenetic features of bacteria causing chronic diarrhea in the developing world.
|
Fumiko Obata,
Ph.D. 410-706-6916
Microbiology and Immunology
Research:
|
Diana Oram,
Ph.D. 410-706-8705
Department of Microbial Pathogenesis
Research: Gram positive bacterial pathogenesis
|
Yuko Ota,
Ph.D. 410-706-5161
Department of Microbiology and Immunology
Research: My current research interests are the search for the origins of immune genes and the manner by which the immune system was shaped over evolutionary time.
|
Zeev Pancer,
Ph.D. 410-234-8834
Center of Marine Biotechnology, UMBI
Research: Comparative Immunology; Origin of vertebrate adaptive immunity - Rearranging antigen receptors of jawless vertebrates - Molecular mechanisms of invertebrate and vertebrate immunity.
|
Macela Pasetti,
Ph.D. 410-706-2341
Department of Pediatrics
Research: Dr. Pasetti’s research focuses in the evaluation and characterization of immune responses induced by Shigella and Salmonella live vector vaccines expressing bacterial, protozoal, and viral antigens.
|
C. David Pauza,
Ph.D. 410-706-1367
Institute of Human Virology
Research: Cinical and animal model research on HIV/AIDS and the development of preventive or therapeutic vaccines.
|
Christopher Plowe,
M.D, M.P.H. 410-706-3082
Department of Medicine
Research: Malaria drug resistance, clinical trials of malaria drugs and vaccines, molecular epidemiology, malaria pathogenesis, malaria-HIV interactions
|
Mikulas Popovic,
M.D., Ph.D. 410-706-5879
Institute of Human Virology/Microbiology and Immunology
Research: Studies of Immune-modulating Activities of HIV-1Tat and HIV-1p17
|
David Rasko,
Ph.D. 410-706-6774
Department of Microbiology and Immunology
Research:
|
Jacques Ravel,
Ph.D. 410-706-5674
Department of Microbiology & Immunology
Research: Exploring the human microbiome: ecology and metagenomics, Microbial genome sequence comparative analyses: the making of a genome with a special emphasis on human microbial pathogens
|
Robert Redfield,
M.D. 410-706-4631
Institute of Human Virology/Microbiology and Immunology
Research: development of biological approaches for the treatment of chronic viral pathogens with a present-day focus on HIV
|
Marvin Reitz,
Ph.D. 410-706-4679
Institute of Human Virology
Research: Human herpesvirus 8 (HHV-8) and its role in human diseases; Chemokines and HIV-1;
|
John Sacci,
Ph.D. 410-706-4071
Department of Microbiology and Immunology
Research: The principle area of my research has been the study of protozoan parasites and how they interact with their respective hosts.
|
Maria Salvato,
Ph.D. 410-706-1368
Institute of Human Virology
Research: Pathogenesis of arenavirus hemorrhagic fever and arenavirus vaccines. Mechanisms of virus-mediated cell death in AIDS. Use of animal models, and genomic/proteomic approaches to analyze virus/host interactions.
|
Connie Schmaljohn,
Ph.D. 310-619-4103
Microbiology and Immunology
Research: Studies are focused toward developing vaccines and therapeutics to combat militarily relevant agents of disease.
|
Dan Schulze,
Ph.D. 410-706-5180
Department of Microbiology and Immunology
Research: My laboratory has developed an interest in molecular characterization of membrane transport molecules that regulate calcium (Ca) in cells.
|
David Scott,
Ph.D. 410-706-8069
Department of Surgery
Research: Our laboratory focuses on understanding how this self "tolerance" (or unresponsiveness) is learned by both B cells and T cells and applying it using a novel gene therapy approach.
|
Jyoti Misra Sen,
M.Sc., Ph.D. 410-558-8163
NIH/NIA Laboratory of Immunology
Research: The long-term goal of our research is to define molecular interactions that are significant in the reconstitution of a functional immune system in adult mouse.
|
Mark Shirtliff,
Ph.D. 410-706-2263
Department of Microbial Pathogenesis
Research: My laboratory is presently using 2D gel electrophoresis, microarray analysis, reporter systems, and knockouts to identify biofilm specific genes and their products in Staphylococcus aureus and Proteus mirabilis.
|
Mark Strauch,
Ph.D. 410-706-1815
Department of Microbial Pathogenesis
Research: DNA-binding proteins and global regulation of gene expression in Bacillus and Listeria
|
Scott1 Strome,
M.D. 410-328-6467
Department of Otorhinolaryngology-Head and Neck Surgery
Research: Dr. Strome's research program is focused on the study of mechanisms to harness the immune response to squamous cell carcinoma of the head and neck (SCCHN) for purposes of diagnoses/monitoring and therapy.
|
Marcelo Sztein,
M.D. 6-5328
Department of Pediatrics/Center for Vaccine Development
Research: Current projects encompass the study of systemic and mucosal innate and adaptive immune responses in volunteers participating in vaccine trials being conducted at the CVD and other sites.
|
Koji Tamada,
M.D., Ph.D. 410-328-0372
Department of Otorhinolaryngology-Head and Neck Surgery
Research: Immunotherapy of cancer, transplantation, infectious diseases, and autoimmunity.
|
Hervé Tettelin,
Ph.D. 410-706-6764
Department of Microbiology and Immunology
Research: Dr. Tettelin’s research focuses on the use of genomics and functional genomics to understand bacterial virulence, study host-pathogen interactions, and identify vaccine candidates and drug targets to cure disease.
|
Stefanie Vogel,
Ph.D. 410-706-4838
Department of Microbiology and Immunology
Research: Dr. Vogel’s research is focused on the capacity of macrophages to respond to bacterial products such as the endotoxic lipopolysaccharide (LPS) of Gram negative bacteria.
|
Tonya J. Webb,
PhD (410) 706-4109
Microbiology & Immunology
Research:
|
Mark Williams,
Ph.D. 410-706-8204
Department of Microbiology and Immunology
Research: The major focus of my lab is to investigate the mechanisms by which reactive oxygen or nitrogen species affect the immune system.
|
Li Zhang,
Ph.D. 410-706-8040
Department of Physiology
Research: Biology of leukocyte integrins, especially the CD18 integrin subfamily, and their roles in physiological and pathological processes
|
Richard Zhao,
Ph.D. 410-706-6301
www.zhaolab.us
Departments of Pathology, Microbiology-Immunology
Research: Virus-host interactions and their roles in cell cycle G2/M regulation, apoptosis and host innate antiviral responses; HIV-1 Vpr; Human biology and virology; Fission yeast genetics |